[Some aspects of treatment and prevention of occupational allergic dermatoses]. 1972

Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D009783 Dermatitis, Occupational A recurrent contact dermatitis caused by substances found in the work place. Occupational Dermatitis,Dermatosis, Industrial,Industrial Dermatosis,Dermatitides, Occupational,Dermatoses, Industrial,Industrial Dermatoses,Occupational Dermatitides
D011482 Protective Devices Devices designed to provide protection against injury. Safety Devices,Device, Protective,Device, Safety,Devices, Protective,Devices, Safety,Protective Device,Safety Device
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
February 1956, Journal of the American Medical Association,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
November 1958, Journal of the American Medical Association,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
October 1966, La Revue lyonnaise de medecine,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
December 1951, Medicina del deporte y del trabajo,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
October 1979, Meditsinskaia sestra,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
March 1970, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
March 1957, Belgisch tijdschrift voor geneeskunde,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
October 1961, Ceskoslovenska dermatologie,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
January 1955, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
Iu K Skripkin, and B A Somov, and Butov Ius, and E A Ievleva, and G D Selisskiĭ
August 1968, Klinicheskaia meditsina,
Copied contents to your clipboard!